We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for penpulimab (Specialised Therapeutics Pharma Pty Ltd)
Active ingredients
penpulimab
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Solution for intravenous infusion
Indication
Treatment of nasopharyngeal carcinoma
Therapeutic area
Oncology